ZIVO Bioscience Overview

  • Founded
  • 1983

Founded
  • Status
  • Public

  • Employees
  • 10

Employees
  • Stock Symbol
  • ZIVO

Stock Symbol
  • Investments
  • 3

  • Share Price
  • $3.86

  • (As of Monday Closing)

ZIVO Bioscience General Information

Description

Zivo Bioscience Inc is a biotechnology company that is engaged in selling natural bioactive ingredients derived from proprietary algae cultures to animal, human and dietary supplement and medical food manufacturers. The company focuses on research and identification of its bioactive ingredients. It also develops tests that allow people to optimize their health and identify future health risks. The company's product candidate ZIVO algae strain is a human dietary supplement that acts as a source of non-animal nutrition, animal supplement, and livestock feed additive, boosting productivity and overall health. Its other product categories are animal applications, human applications, functional food ingredient, dietary supplements and nutraceuticals, and medical food and Botanical Drug.

Contact Information

Formerly Known As
Health Enhancement Products, Health Enhancement
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 21 East Long Lake Road
  • Suite 100
  • Bloomfield Hills, MI 48320
  • United States
+1 (248) 000-0000 000. 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ZIVO Bioscience Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.86 $3.70 $2.37 - $7.90 $36.4M 9.4M 13.3K -$1.00

ZIVO Bioscience Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 31,336 15,919 66,794 66,639
Revenue 0 0 20 0
EBITDA (9,191) (8,930) (8,556) (8,352)
Net Income (9,199) (9,163) (9,106) (11,510)
Total Assets 5,865 8,990 220 369
Total Debt 833 255 5,355 5,280
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ZIVO Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ZIVO Bioscience‘s full profile, request access.

Request a free trial

ZIVO Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Zivo Bioscience Inc is a biotechnology company that is engaged in selling natural bioactive ingredients derived from pro
Biotechnology
Bloomfield Hills, MI
10 As of 2021
00000
00000000 00000

000000

eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
00000000000
Taoyuan, Taiwan
0000 As of 0000
0000 0000-00-00
000000000000

000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
00000 000000000 00000000
Minneapolis, MN
000000 As of 0000
000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ZIVO Bioscience Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Grobest Private Equity-Backed Taoyuan, Taiwan 0000 000000000000
0000000 Private Debt Financed Minneapolis, MN 000000 000000000
000000 0000000 Corporate Backed or Acquired Aarhus, Denmark 000 000000000
0000000 000000 Corporate Backed or Acquired Chicago, IL 00000 000000 - 000
00000é Corporation Vevey, Switzerland 000000 00.00 000000000 00.00
You’re viewing 5 of 5 competitors. Get the full list »

ZIVO Bioscience Patents

ZIVO Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220016240-A1 Immune priming to accelerate/enhance immune response through administration of natural immune modulator Pending 26-Jun-2020 0000000000
US-20220053799-A1 Positive latency effects on coccidiosis prevention and treatment via animal feed Pending 26-Jun-2020 000000000
US-20210353732-A1 Use of tlr4 modulator in the treatment of coccidiosis Pending 14-May-2020 000000000
EP-3897188-A1 Algal feed ingredient for controlling the effects of coccidiosis and necrotic enteritis in poultry Pending 21-Dec-2018 000000000
CA-3124190-A1 Algal feed ingredient for controlling the effects of coccidiosis and necrotic enteritis in poultry Pending 21-Dec-2018 A61K36/05
To view ZIVO Bioscience’s complete patent history, request access »

ZIVO Bioscience Executive Team (4)

Name Title Board Seat Contact Info
John Payne Chief Executive Officer & Chairman
Keith Marchiando Chief Financial Officer, Finance & Secretary, Administration
You’re viewing 2 of 4 executive team members. Get the full list »

ZIVO Bioscience Board Members (7)

Name Representing Role Since
000000 0000000 ZIVO Bioscience Board Member 000 0000
0000 00000 ZIVO Bioscience Chief Executive Officer & Chairman 000 0000
You’re viewing 2 of 7 board members. Get the full list »

ZIVO Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ZIVO Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ZIVO Bioscience‘s full profile, request access.

Request a free trial

ZIVO Bioscience Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 22-Aug-2013 0000000000 Monitoring Equipment
00000000 0000 19-Aug-2013 0000000000 00.00 Asset Management 000000 00
Western Glory Hole 09-Oct-2003 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view ZIVO Bioscience’s complete acquisitions history, request access »